A detailed history of Invesco Ltd. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Invesco Ltd. holds 874,665 shares of NBIX stock, worth $111 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
874,665
Previous 1,258,104 30.48%
Holding current value
$111 Million
Previous $173 Million 41.86%
% of portfolio
0.02%
Previous 0.04%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$114.58 - $153.15 $43.9 Million - $58.7 Million
-383,439 Reduced 30.48%
874,665 $101 Million
Q2 2024

Aug 13, 2024

BUY
$130.86 - $143.19 $15.9 Million - $17.3 Million
121,162 Added 10.66%
1,258,104 $173 Million
Q1 2024

May 14, 2024

BUY
$130.4 - $143.74 $60.4 Million - $66.6 Million
463,134 Added 68.73%
1,136,942 $157 Million
Q4 2023

Feb 12, 2024

BUY
$106.07 - $132.76 $30.5 Million - $38.2 Million
287,693 Added 74.51%
673,808 $88.8 Million
Q3 2023

Nov 13, 2023

SELL
$94.02 - $117.1 $16.6 Million - $20.6 Million
-176,245 Reduced 31.34%
386,115 $43.4 Million
Q2 2023

Aug 11, 2023

SELL
$89.53 - $104.87 $1.25 Million - $1.46 Million
-13,914 Reduced 2.41%
562,360 $53 Million
Q1 2023

May 12, 2023

SELL
$94.11 - $123.02 $80.1 Million - $105 Million
-851,005 Reduced 59.62%
576,274 $58.3 Million
Q4 2022

Feb 13, 2023

BUY
$106.72 - $127.06 $55.7 Million - $66.3 Million
521,568 Added 57.59%
1,427,279 $170 Million
Q3 2022

Nov 14, 2022

BUY
$92.03 - $107.81 $58.5 Million - $68.5 Million
635,394 Added 235.06%
905,711 $96.2 Million
Q2 2022

Aug 15, 2022

BUY
$75.79 - $100.07 $1.4 Million - $1.85 Million
18,452 Added 7.33%
270,317 $26.4 Million
Q1 2022

May 16, 2022

SELL
$72.45 - $94.81 $2.12 Million - $2.77 Million
-29,253 Reduced 10.41%
251,865 $23.6 Million
Q4 2021

Feb 14, 2022

SELL
$79.65 - $106.22 $3.72 Million - $4.96 Million
-46,693 Reduced 14.24%
281,118 $23.9 Million
Q3 2021

Nov 15, 2021

SELL
$86.18 - $99.03 $66 Million - $75.9 Million
-766,088 Reduced 70.03%
327,811 $31.4 Million
Q2 2021

Aug 17, 2021

BUY
$89.43 - $102.27 $584,335 - $668,232
6,534 Added 0.6%
1,093,899 $106 Million
Q1 2021

May 17, 2021

BUY
$87.57 - $119.4 $369,895 - $504,345
4,224 Added 0.39%
1,087,365 $106 Million
Q4 2020

Feb 16, 2021

SELL
$86.91 - $108.33 $56.5 Million - $70.5 Million
-650,332 Reduced 37.52%
1,083,141 $104 Million
Q3 2020

Nov 16, 2020

SELL
$96.16 - $135.15 $21.1 Million - $29.7 Million
-219,836 Reduced 11.25%
1,733,473 $167 Million
Q2 2020

Aug 14, 2020

BUY
$85.09 - $130.36 $81.6 Million - $125 Million
959,127 Added 96.47%
1,953,309 $238 Million
Q1 2020

May 15, 2020

SELL
$75.11 - $113.76 $9.33 Million - $14.1 Million
-124,255 Reduced 11.11%
994,182 $86 Million
Q4 2019

Feb 14, 2020

SELL
$86.8 - $118.57 $17.8 Million - $24.3 Million
-204,879 Reduced 15.48%
1,118,437 $120 Million
Q3 2019

Nov 14, 2019

BUY
$83.82 - $101.5 $3.77 Million - $4.57 Million
45,004 Added 3.52%
1,323,316 $119 Million
Q2 2019

Aug 14, 2019

SELL
$72.24 - $91.27 $46.6 Million - $58.8 Million
-644,606 Reduced 33.52%
1,278,312 $108 Million
Q1 2019

May 15, 2019

SELL
$69.31 - $91.53 $14.3 Million - $18.9 Million
-205,944 Reduced 9.67%
1,922,918 $169 Million
Q4 2018

Feb 14, 2019

BUY
$68.32 - $124.36 $145 Million - $265 Million
2,128,862 New
2,128,862 $152 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12.1B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.